Indian CRDMOs Gain As Global Pharma Diversifies: Jefferies
The Business Guardian
|June 28, 2025
Indian CRDMOs (Contract Research and Development and Manufacturing Organizations) are seeing growing interest from global pharmaceutical companies, according to a recent report by Jefferies.
The report highlighted that Big Pharma companies are increasingly diversifying their manufacturing and research operations geographically, and Indian companies with expertise in small molecule development are well placed to benefit.
It said "Big Pharma is diversifying geographically, benefiting Indian CRDMOs with small molecule expertise."
The report highlighted some major pharma companies (including Piramal Pharma, Syngene, Laurus Labs, Cohance, Gland Pharma).
The report said that these companies highlighted that many of the ongoing projects are still in the clinical stages, so growth may be uneven.
There is also a rising demand for antibody-drug conjugate (ADC)-related CDMO services, and Indian companies are exploring opportunities in that space.
Bu hikaye The Business Guardian dergisinin June 28, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
The Business Guardian'den DAHA FAZLA HİKAYE
The Business Guardian
RECORD ORDERS, RECORD ANGER: THE TWO REALITIES OF NEW YEAR'S EVE
New Year's Eve proves the money exists—workers just don't get it on ordinary days. The app can raise pay in a flash; it just won't make it permanent.
8 mins
January 03, 2026
The Business Guardian
South Korea's exports hit record USD 700bn in 2025
South Korea's outbound shipments surpassed the USD 700 billion mark for the first time in 2025, driven primarily by robust global demand for semiconductors and record automobile sales.
1 min
January 03, 2026
The Business Guardian
Supply constraints support copper, aluminium; Iron ore prices likely to ease: Report
Metals are expected to outperform in 2026, driven by tight supply and strong demand, according to ING’s Commodities Outlook 2026.
2 mins
January 03, 2026
The Business Guardian
GOVT TO FILE FIR AGAINST KEJRIWAL: ASHISH SOOD
Sood alleged that Kejriwal circulated false information through a tweet, prompting the government to register an FIR
1 mins
January 03, 2026
The Business Guardian
No arrests 3 days after Noida SUV crash kills two, families protest at DM's office
Three days after a horrific incident in Noida’s Sector 39 police station area that took the lives of two young men, the Noida Police have yet to make any arrests.
1 min
January 03, 2026
The Business Guardian
Shankh Air to commence operations in March, eyes international routes by 2029
Shankh Air, an upcoming domestic airline venture, plans to take to the skies by the first quarter of 2026.
1 mins
January 03, 2026
The Business Guardian
NIFTY 50 SETTLES AT RECORD HIGH, SENSEX JUMPS 573 PTS
Market sentiment remained positive, supported by stable domestic macro fundamentals and continued confidence in India's medium-term growth trajectory.
1 mins
January 03, 2026
The Business Guardian
Fiscal deficit widens to Rs 9.77 lakh crore in April-November FY26
India's fiscal position during the April-November period of FY26 indicates that concerns over lagging tax revenues and adherence to the full-year budget targets have resurfaced, even as the government continues to prioritise capital expenditure-led growth, as per a report by Union Bank of India.
1 mins
January 03, 2026
The Business Guardian
GRAP-III lifted in as air quality improves
Commission for Air Quality Management (CAQM) on Friday revoked Stage-III restrictions under the Graded Response Action Plan (GRAP) in Delhi-NCR.
1 mins
January 03, 2026
The Business Guardian
Nearly 80% of FY26 investments flow to five sectors, infrastructure on top: BoB Report
Nearly 80% of FY26 investments flow to five sectors, infrastructure on top: BoB Report New Delhi
1 mins
January 03, 2026
Listen
Translate
Change font size